51 results on '"Cazzagon N."'
Search Results
2. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
3. T.08.3 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND HEPATOCELLULAR CARCINOMA
4. Surveillance of hepatobiliary cancers in primary sclerosing cholangitis: a preliminary study on the role of PET-MRI
5. Lifestyle in Primary Biliary Cholangitis: let's pay attention!
6. Predictors of Serious Adverse Event and Non-response in Cirrhotic Patients With Primary Biliary Cholangitis under Obeticholic Acid
7. Persistent biochemical alteration at one year can lead to worse clinical outcomes in autoimmune hepatitis
8. Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis
9. Preventing hepatic fibrogenesis with the two extra-virgin olive oil polyphenols tyrosol and hydroxytyrosol via NOX inhibition
10. Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group
11. A novel HER2-targeted liposomal formulation reduces the risk of hepatotoxicity induced by PEG-based anticancer drugs
12. Inhibiting NOXs with extra-virgin olive oil polyphenols as a strategy to prevent hepatic fibrogenesis
13. Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase
14. Role of cellular senescence in the natural history of primary sclerosing cholangitis
15. Perception of illness in Italian patients with Primary Biliary Cholangitis referred to tertiary care units
16. Magnetic resonance risk score and liver stiffness by transient elastography have complementary prognostic values in patients with Primary Sclerosing Cholangitis
17. Magnetic resonance cholangiography and biochemical predictive criteria of response to endoscopic treatment of severe strictures in patients with primary sclerosing Cholangitis
18. Two simple magnetic resonance scores are able to predict survival in patients with Primary Sclerosing Cholangitis
19. Hepatobiliary and non-hepatobiliary malignancies in PSC patients from Southern Europe: a comparative study in two European centers
20. THU-205 - Morning bright light treatment for sleep-wake disturbances in Primary Biliary Cholangitis (PBC)
21. THU-236 - Risk stratification using transient elastography and the new scoring systems for patients with primary biliary cholangitis
22. Primary Biliary Cholangitis (PBC): The emotional perception of the disease journey from a patient's perspective
23. Primary biliary cholangitis (PBC): The patient journey to diagnosis and through the disease
24. Autoimmune hepatitis in children and adults: A single centre experience
25. Impairment of coronary microvascular function in patients with Primary Biliary Cholangitis
26. Extrahepatic autoimmunity in patients with autoimmune hepatitis (AIH)
27. Primary biliary cholangitis in elderly patients
28. SAT-349 - Autoimmune Hepatitis: Clinical, Laboratory and Survival Analysis in Children and Adults
29. SAT-364 - Extrahepatic Autoimmunity in Patients with Autoimmune Hepatitis
30. FRI-392 - Primary Biliary Cholangitis in Elderly Patients
31. P1209 : Coronary microvascular dysfunction in patients with primary biliary cirrhosis without metabolic syndrome: A hint for their increased cardiovascular risk
32. P1184 : Age, bilirubin and albumin, regardless of sex, are the strongest independent predictors of biochemical response and transplantation-free survival in patients with primary biliary cirrhosis
33. P1185 : Effectiveness of Adalimumab for patients with primary sclerosing cholangitis associated with inflammatory bowel disease
34. P1180 : Identification of pbc patients in need of additional therapy during the course of UDCA treatment -an international multicenter study
35. P1177 : Risk factors for hepatic decompensation in primary biliary cirrhosis - results of an international follow up study of 2326 patients
36. Coronary microvascular dysfunction in patients with primary biliary cirrhosis without metabolic syndrome: a hint for their increased cardiovascular risk
37. Effectiveness of Adalibumab for patients with primary sclerosing cholangitis associated with inflammatory bowel disease
38. P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC
39. Pregnancy and primary biliary cirrhosis: A case–control study
40. Incidence and risk factors for extra-hepatic malignancies in primary biliary cirrhosis: A comparative study from two European referral centers
41. F-25 The prognostic role of magnetic resonance cholangiography in primary sclerosing cholangitis (PSC)
42. OC-07 Primary biliary cirrhosis and metabolic syndrome
43. P.15.11 A PROSPECTIVE CONTROLLED TRIAL ON THE EFFICACY AND TOLERABILITY OF ANTIVIRAL THERAPY IN ILLICIT DRUG USERS WITH CHRONIC HEPATITIS C RECEIVING METHADONE MAINTENANCE TREATMENT
44. P.08.22 PROGNOSTIC ROLE OF SCCA-IGM SERUM LEVELS IN HEPATOCELLULAR CARCINOMA (HCC)
45. P.1.274: PROTECTIVE EFFECT OF COFFEE ON OXIDATIVE DNA DAMAGE, TELOMERE LENGTH AND APOPTOSIS IN PATIENTS WITH HCV-RELATED CHRONIC HEPATITIS
46. P.1.158: PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE
47. T-14 The outcome of pregnancy in patients with primary sclerosing cholangitis
48. T-4 A 20-years survey by ITA.LI.CA on hepatocellular carcinoma (HCC) in HCV-related cirrhosis
49. P1 Primary biliary cirrhosis: time for sleep
50. OC5 The natural history of autoimmune hepatitis/primary sclerosing cholangitis (AIH/PSC) overlap syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.